Stock Events

Stock Events

BeyondSpring 

$1.73
20
+$0.02+0.88% Thursday 20:00

Statistics

Day High
1.73
Day Low
1.66
52W High
3.44
52W Low
0.98
Volume
2,265
Avg. Volume
28,208
Mkt Cap
69.57M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

17JunExpected
Q1 2024
Q2 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.05
0
0.06
0.11
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-22.25MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BYSI. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a global healthcare company that develops medications in oncology, among other areas, directly competing with BeyondSpring's cancer treatment pipeline.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb operates in the biopharmaceutical industry focusing on cancer treatments, making it a direct competitor to BeyondSpring's oncology-focused therapies.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including cancer drugs, competing with BeyondSpring's offerings.
AMGEN
AMGN
Mkt Cap160.66B
Amgen Inc. focuses on human therapeutics, including oncology/hematology, which competes with BeyondSpring's cancer treatment developments.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences, Inc. is a biopharmaceutical company that develops and markets therapies in areas including oncology, competing with BeyondSpring's cancer drugs.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca PLC is a multinational pharmaceutical and biopharmaceutical company with a strong emphasis on oncology, making it a competitor to BeyondSpring.
Novartis
NVS
Mkt Cap237.61B
Novartis AG focuses on patented medicines across multiple segments, including oncology, directly competing with BeyondSpring's cancer therapies.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG specializes in pharmaceuticals and diagnostics. Its strong focus on oncology research and treatments makes it a competitor to BeyondSpring.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the pharmaceutical, medical devices, and consumer health sectors, with its pharmaceutical segment competing in oncology.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals, Inc. is known for its innovation in biotechnology, including oncology, competing with BeyondSpring's research and drug development.

About

BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of NSCLC; nivolumab and ipilimumab, a CTLA-4 antibody for the treatment of SCLC; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.
Show more...
CEO
Dr. Lan Huang Ph.D.
Employees
40
Country
KY
ISIN
KYG108301006

Listings

XNAS
US
BYSI
BOATS
BOATS
BYSI.BOATS

0 Comments

Share your thoughts

FAQ

What is BeyondSpring stock price today?▼
The current price of BYSI is $1.73 USD — it has increased by +0.88% in the past 24 hours. Watch BeyondSpring stock price performance more closely on the chart.
What is BeyondSpring stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange BeyondSpring stocks are traded under the ticker BYSI.
Is BeyondSpring stock price growing?▼
BYSI stock has risen by +7.81% compared to the previous week, the month change is a +11.29% rise, over the last year BeyondSpring has showed a +15% increase.
What is BeyondSpring market cap?▼
Today BeyondSpring has the market capitalization of 69.57M
When is the next BeyondSpring earnings date?▼
BeyondSpring is going to release the next earnings report on June 17, 2026.
What were BeyondSpring earnings last quarter?▼
BYSI earnings for the last quarter are -0.05 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is BeyondSpring revenue for the last year?▼
BeyondSpring revenue for the last year amounts to 0 USD.
What is BeyondSpring net income for the last year?▼
BYSI net income for the last year is -22.25M USD.
How many employees does BeyondSpring have?▼
As of April 03, 2026, the company has 40 employees.
In which sector is BeyondSpring located?▼
BeyondSpring operates in the Health Care sector.
When did BeyondSpring complete a stock split?▼
BeyondSpring has not had any recent stock splits.
Where is BeyondSpring headquartered?▼
BeyondSpring is headquartered in Florham Park, KY.